A Phase1 Study of VIB9600

Exclusion Criteria

• •1. Concurrent enrollment in another clinical study involving an investigational treatment.
• •2. Received administration of an investigational drug or participated in a device trial within 3 months prior to screening (Visit 1).
• •3. Subject is a participating investigator, sub-investigator, study coordinator, or employee of the participating site, or is a first-degree relative of the aforementioned.
• •4. History, or a reason to believe that a subject has a history, of drug or alcohol abuse within the 2 years prior to screening.
• •5. Positive test for drugs of abuse.
• •6. Donation of blood or blood products in excess of 500 mL within 3 months prior to screening. Not agreeing to refrain from blood or blood product donations during study participation.
• •7. Receiving any of the prohibited concomitant medications:
• •1. Any immunotherapy or immunosuppressive therapy
• •2. Chronic use of steroid medications
• •3. Immunoglobulin or blood products
• •4. Live vaccines
• •5. Anticoagulants
• •6. Aspirin